Update on percutaneous mitral valve therapy: Clinical results and real life experience

Minerva Cardioangiologica

Volumn 60, Issue 1, 2012, Pages 57-70

  Ussia, G P ^a,b   Cammalleri, V ^a   Scandura, S ^a   Imme S ^a   Pistritto, A M ^a   Ministeri, M ^a   Chiaranda M ^a   Caggegi, A ^a   Barbanti, M ^a   Aruta, P ^a   Tamburino, C ^a,b  

^a UNIVERSITY OF CATANIA   (Italy)

^b Excellence Through Newest Advances ETNA Foundation   (Italy)

Author keywords

Mitral valve annuloplasty; Mitral valve insufficiency; Risk factors

Indexed keywords

ADVERSE OUTCOME; CARDIAC PATIENT; CARDIOVASCULAR RISK; CLINICAL EFFECTIVENESS; CLINICAL TRIAL (TOPIC); CLIP; CONGESTIVE HEART FAILURE; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; DISEASE SEVERITY; FOOD AND DRUG ADMINISTRATION; HEART EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HIGH RISK PATIENT; HUMAN; MITRAL ANNULOPLASTY; MITRAL VALVE REGURGITATION; MITRAL VALVE REPAIR; MITRAL VALVE REPLACEMENT; OUTCOME ASSESSMENT; PATIENT SAFETY; PATIENT SELECTION; QUALITY OF LIFE; REVIEW; SURGICAL RISK; SURGICAL TECHNIQUE; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TREATMENT CONTRAINDICATION; VASCULAR ACCESS;

CARDIAC SURGICAL PROCEDURES; CLINICAL TRIALS AS TOPIC; EQUIPMENT DESIGN; FORECASTING; HEART CATHETERIZATION; HUMANS; MITRAL VALVE INSUFFICIENCY;

EID: 84858855533     PISSN: 00264725     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (23)

1. Enriquez-Sarano M, Akins CW, Vahanian A. Mitral regurgitation. Lancet 2009;373:1382-94.
2. Vahanian A, Baumgartner H, Bax J, Butchart E, Dion R, Filippatos G et al. Task Force on the Management of Valvular Hearth Disease of the European Society of Cardiology; ESC Committee for Practice Guidelines. Guidelines on the management of valvular heart disease: The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology. Eur Heart J 2007;28:230-68. (Pubitemid 46276943)
3. Bonow RO, Carabello BA, Chatterjee K, de Leon AC Jr, Faxon DP, Freed MD et al.; American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2008 focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1998 guidelines for the management of patients with valvular heart disease). Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol. 2008;52:e1-142.
4. Mirabel M, Iung B, Baron G, Messika-Zeitoun D, Detaint D, Vanoverschelde JL et al. What are the characteristics of patients with severe, symptomatic, mitral regurgitation who are denied surgery? Eur Heart J 2007;28:1358-65. (Pubitemid 47355974)
5. Maisano F, Torracca L, Oppizzi M, Stefano PL, D'Addario G, La Canna G et al. The edge-to-edge technique: a simplified method to correct mitral insufficiency. Eur J Cardiothorac Surg 1998;13:240-5.
6. Alfieri O, Maisano F, De Bonis M, Stefano PL, Torracca L, Oppizzi M et al. The double-orifice technique in mitral valve repair: a simple solution for complex problems. J Thorac Cardiovasc Surg 2001;122:674-81 6.
7. Feldman T, Wasserman HS, Herrmann HC, Gray W, Block PC, Whitlow P et al. Percutaneous mitral valve repair using the edge-to-edge technique: six month results of the EVEREST Phase I Clinical Trial. J Am Coll Cardiol 2005;46: 2134-40. (Pubitemid 41713603)
8. Feldman T, Kar S, Rinaldi M, Fail P, Hermiller J, Smalling R et al. Percutaneous mitral repair with the Mitra-Clip system: safety and midterm durability in the initial EVEREST (Endovascular Valve Edge-to-Edge REpair Study) cohort. J Am Coll Cardiol 2009;54:686-94.
9. Feldman T, Foster E, Glower DG, Kar S, Rinaldi MJ, Fail PS et al. Percutaneous repair or surgery for mitral regurgitation. N Engl J Med 2011;364:1395-406.
10. Ussia GP, Barbanti M, Tamburino C. Feasibility of percutaneous transcatheter mitral valve repair with the MitraClip system using conscious sedation. Catheter Cardiovasc Interv 2010;75:1137-40.
11. Tamburino C, Ussia GP, Maisano F, Capodanno D, La Canna G, Scandura S et al. Percutaneous mitral valve repair with the MitraClip system: acute results from a real world setting. Eur Heart J 2010;31:1382-9.
12. Kar S. Analysis of the EVEREST II High Risk Registry. Two year outcomes. ACC Meeting 2011.
13. Franzen O, Baldus S, Rudolph V, Meyer S, Knap M, Koschyk D et al. Acute outcomes of MitraClip therapy for mitral regurgitation in high-surgical-risk patients: emphasis on adverse valve morphology and severe left ventricular dysfunction. Eur Heart J 2010;31:1373-81.
14. Van den Branden BJ, Post MC, Swaans MJ, Rensing BJ, Eefting FD, Plokker HW et al. Percutaneous mitral valve repair using the edge-to-edge technique in a high-risk population. Neth Heart J 2010;18:437-43.
15. Pleger ST, Mereles D, Schulz-Schönhagen M, Krumsdorf U, Chorianopoulos E, Rottbauer W et al. Acute Safety and 30-Day Outcome After Percutaneous Edge-to-Edge Repair of Mitral Regurgitation in Very High-Risk Patients. Am J Cardiol 2011;108:1478-82.
16. Franzen O, van der Heyden J, Baldus S, Schlüter M, Schillinger W, Butter C et al. MitraClip therapy in patients with end-stage systolic heart failure. Eur J Heart Fail. 2011;13:569-76.
17. Ussia GP, Cammalleri V, Sarkar K, Scandura S, Immè S,Pistritto AM et al. Quality of life following percutaneous mitral valve repair with the MitraClip System. Int J Cardiol 2011 [In press].
18. Maisano F, Franzen O, Baldus S, Hausleiter J, Butter C, Schaefer U et al. Mitraclip™ therapy demonstrates favourable mid-term outcomes in ACCESS-EUROPE heart failure patients with left ventricular ejection fraction. Preliminary report from the 6-month ACCESS-EU analysis cohort Eurointervention Volume 7, Supplement M, May 2011.
19. Maisano F, Viganò G, Blasio A, Colombo A, Calabrese C, Alfieri O. Surgical isolated edge-to-edge mitral valve repair without annuloplasty: clinical proof of the principle for an endovascular approach. EuroIntervention 2006;2:181-6.
20. Harnek J, Webb JG, Kuck KH, Tschope C, Vahanian A, Buller CE et al. Transcatheter implantation of the MONARC coronary sinus device for mitral regurgitation 1-year results from the EVOLUTION phase I study (Clinical Evaluation of the Edwards Lifesciences Percutaneous Mitral Annuloplasty System for the Treatment of Mitral Regurgitation). J Am Coll Cardiol Interv 2011;4:115-22.
21. Sack S, Kahlert P, Bilodeau L, Pièrard LA, Lancellotti P, Legrand V et al. Percutaneous transvenous mitral annuloplasty: initial human experience with a novel coronary sinus implant device. Circ Cardiovasc Interv 2009;2:277-84.
22. Siminiak T, Hoppe UC, Schofer J, Haude M, Herman JP, Vainer J et al. Effectiveness and safety of percutaneous coronary sinus-based mitral valve repair in patients with dilated cardiomyopathy (from the AMADEUS trial). Am J Cardiol 2009;104:565-70.
23. Schofer J, Siminiak T, Haude M, Herrman JP, Vainer J, Wu JC et al. Percutaneous mitral annuloplasty for functional mitral regurgitation: results of the CARILLON Mitral Annuloplasty Device European Union Study. Circulation 2009;120:326-33.